Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Darrell White
DEWS III update: Another bloated effort, little new to offer
While enjoying a rare extended and relaxed lunch break on a clinic day, I read an article on the latest Dry Eye Workshop offering from the Tear Film & Ocular Surface Society that included interviews of working group members and authors. Which led me to the official publication in the American Journal of Ophthalmology. Which led me to the medicine cabinet and a couple of extra-strength Tums.
BLOG: A commentary on Bausch + Lomb
Purpose-built for physicians Learn more Dry Eye and Other Fancies October 16, 2026 3 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts You've successfully added to your alerts. You will receive an email when new content is published.
Identification of broadly tumour-reactive γδ TCRs from multiple myeloma
|
Abstract γδ T cells are becoming increasingly appreciated for their antitumour capacity and role in mediating responses to immune checkpoint blockade1,2,3. Unlike classical αβ T cells, the degree to which γδ T cells rely on their T cell receptors (TCRs) to induce antitumour responses remains unclear.
By Michael St. Paul, Liam D Hendrikse, Fan Ying, Bryan Snow, Ping Luo, Simone Helke, Logan Smith, Arwa Hilal, Dor D Abelman, Matthew J Gold, Chantal Tobin, Scott Lien, Yi Liu, Wenjing Zhou, Xin Zhang, Dat Nguyen, Stephanie Pedersen Verified, Mary Saunders, Thorsten Berger, Andrew Wakeham, David Scott, Dalam Ly, Cecilia Bonolo de Campos, Guanghao Liang, Chunxing Zheng, Wesley Wilson, Esther Masih-Khan, Darrell White, Arleigh McCurdy, Martha Louzada, Rami Kotb, Michael Chu, Stephen Parkin, Donna E Reece, Engin Gul, Rodger E. Tiedemann, Trevor J. Pugh, Naoto Hirano, Pamela S Ohashi, A. Stewart, Suzanne Trudel, Tak W. Mak, Nisha Ramamurthy, Hayley Nault, Ellen N. Wei, Oluwatobi Agbede, Jenna Eagles
|
Nature
Verified
Sometimes I sits and thinks
Purpose-built for physicians Learn more The Dry Eye August 19, 2026 5 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts You've successfully added to your alerts. You will receive an email when new content is published.
Sometimes I sits and thinks
Purpose-built for physicians Learn more The Dry Eye August 19, 2026 5 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts You've successfully added to your alerts. You will receive an email when new content is published.
Sometimes I sits and thinks
Column The Dry Eye Sometimes I sits and thinks August 19, 2026 5 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Best practices for meibomian gland dysfunction, part 1
Recent data suggest that 85% of dry eye disease in the U.S. is partially or completely evaporative dry eye. This means that 85% of dry eye disease (DED) likely originates in the meibomian glands of affected patients. Now is as good a time as any to review best practices for evaluating and treating meibomian gland dysfunction (MGD).
FDA grants urcosimod 0.05% single-patient use for neuropathic corneal pain
Key takeaways: Urcosimod 0.05% has been granted compassionate use designation for a patient with neuropathic corneal pain. The treatment will be studied in a phase 2b/3 study later this year. The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with neuropathic corneal pain, according to a press release from Okyo.
Addressing Demodex essential for effective ocular surface management
Ask a clinical question and tap into Healio AI's knowledge base. Until recently, Demodex blepharitis was often overlooked as a common cause of irritation, according to a panel discussion at OSN New York. Eric D. Donnenfeld, MD, Jai G. Parekh, MD, MBA, and Darrell E. White, MD, discussed the impact that Demodex mites can have on the ocular surface.
Newer players update the basics in dry eye treatment
Once upon a time, dry eye disease was simple. Like a desert, an eye with dry eye disease (DED) simply had too little water to get the job done. It makes me chuckle when I see modern medications that have little or nothing to do with tear volume evaluated in clinical trials named after famous deserts.
Sometimes I sits and thinks
August 15, 2025 5 min read Sometimes I sits and thinks Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Summer has arrived with a molten thud here on America’s North Coast.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Darrell
Contact Darrell, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack